Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 42 |
| Other current assets | 5 |
| TOTAL | $47 |
| Non-Current Assets | |
| TOTAL | $N/A |
| Total Assets | $47 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 1,514 |
| TOTAL | $2,779 |
| Non-Current Liabilities | |
| TOTAL | $N/A |
| Total Liabilities | $2,779 |
| Shareholders' Equity | |
| Retained earnings | -6,308 |
| TOTAL | $-2,732 |
| Total Liabilities And Equity | $47 |